Home > Research > Publications & Outputs > Group cognitive–behavioural therapy for schizop...
View graph of relations

Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial. / Barrowclough, Christine; Haddock, Gillian; Lobban, Fiona et al.

In: British Journal of Psychiatry, Vol. 189, No. 6, 12.2006, p. 527-532.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Barrowclough, C, Haddock, G, Lobban, F, Jones, SH, Siddle, R, Roberts, C & Gregg, L 2006, 'Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial.', British Journal of Psychiatry, vol. 189, no. 6, pp. 527-532. https://doi.org/10.1192/bjp.bp.106.021386

APA

Barrowclough, C., Haddock, G., Lobban, F., Jones, S. H., Siddle, R., Roberts, C., & Gregg, L. (2006). Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial. British Journal of Psychiatry, 189(6), 527-532. https://doi.org/10.1192/bjp.bp.106.021386

Vancouver

Barrowclough C, Haddock G, Lobban F, Jones SH, Siddle R, Roberts C et al. Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial. British Journal of Psychiatry. 2006 Dec;189(6):527-532. doi: 10.1192/bjp.bp.106.021386

Author

Barrowclough, Christine ; Haddock, Gillian ; Lobban, Fiona et al. / Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial. In: British Journal of Psychiatry. 2006 ; Vol. 189, No. 6. pp. 527-532.

Bibtex

@article{b41d439281da464ba1bf62e7a2743409,
title = "Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial.",
abstract = "Background The efficacy of cognitive–behavioural therapy for schizophrenia is established, butthere is less evidence for a group format. Aims To evaluate the effectiveness of group cognitive–behavioural therapy for schizophrenia. Method In all, 113 people with persistent positive symptoms of schizophrenia were assigned to receive group cognitive–behavioural therapy or treatment as usual. The primary outcome was positive symptom improvement on the Positive and Negative Syndrome Scales. Secondary outcome measures included symptoms, functioning, relapses, hopelessness and self-esteem. Results There were no significant differences between the cognitive–behavioural therapy and treatment as usual on measures of symptoms or functioning or relapse, but group cognitive–behavioural therapy treatment resulted in reductions in feelings of hopelessness and in low self-esteem. Conclusions Although group cognitive–behavioural therapy may not be the optimum treatment method for reducing hallucinations and delusions, it may have important benefits, including feeling less negative about oneself and less hopeless for the future.",
author = "Christine Barrowclough and Gillian Haddock and Fiona Lobban and Jones, {Steven H.} and Ron Siddle and Chris Roberts and Lynsey Gregg",
year = "2006",
month = dec,
doi = "10.1192/bjp.bp.106.021386",
language = "English",
volume = "189",
pages = "527--532",
journal = "British Journal of Psychiatry",
issn = "0007-1250",
publisher = "Royal College of Psychiatrists",
number = "6",

}

RIS

TY - JOUR

T1 - Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial.

AU - Barrowclough, Christine

AU - Haddock, Gillian

AU - Lobban, Fiona

AU - Jones, Steven H.

AU - Siddle, Ron

AU - Roberts, Chris

AU - Gregg, Lynsey

PY - 2006/12

Y1 - 2006/12

N2 - Background The efficacy of cognitive–behavioural therapy for schizophrenia is established, butthere is less evidence for a group format. Aims To evaluate the effectiveness of group cognitive–behavioural therapy for schizophrenia. Method In all, 113 people with persistent positive symptoms of schizophrenia were assigned to receive group cognitive–behavioural therapy or treatment as usual. The primary outcome was positive symptom improvement on the Positive and Negative Syndrome Scales. Secondary outcome measures included symptoms, functioning, relapses, hopelessness and self-esteem. Results There were no significant differences between the cognitive–behavioural therapy and treatment as usual on measures of symptoms or functioning or relapse, but group cognitive–behavioural therapy treatment resulted in reductions in feelings of hopelessness and in low self-esteem. Conclusions Although group cognitive–behavioural therapy may not be the optimum treatment method for reducing hallucinations and delusions, it may have important benefits, including feeling less negative about oneself and less hopeless for the future.

AB - Background The efficacy of cognitive–behavioural therapy for schizophrenia is established, butthere is less evidence for a group format. Aims To evaluate the effectiveness of group cognitive–behavioural therapy for schizophrenia. Method In all, 113 people with persistent positive symptoms of schizophrenia were assigned to receive group cognitive–behavioural therapy or treatment as usual. The primary outcome was positive symptom improvement on the Positive and Negative Syndrome Scales. Secondary outcome measures included symptoms, functioning, relapses, hopelessness and self-esteem. Results There were no significant differences between the cognitive–behavioural therapy and treatment as usual on measures of symptoms or functioning or relapse, but group cognitive–behavioural therapy treatment resulted in reductions in feelings of hopelessness and in low self-esteem. Conclusions Although group cognitive–behavioural therapy may not be the optimum treatment method for reducing hallucinations and delusions, it may have important benefits, including feeling less negative about oneself and less hopeless for the future.

U2 - 10.1192/bjp.bp.106.021386

DO - 10.1192/bjp.bp.106.021386

M3 - Journal article

VL - 189

SP - 527

EP - 532

JO - British Journal of Psychiatry

JF - British Journal of Psychiatry

SN - 0007-1250

IS - 6

ER -